CD1a promotes systemic manifestations of skin inflammation. by Hardman, CS, Chen, Y-L, Wegrecki, M, Ng, SW, Murren, R, Mangat, D, Silva, J-P, Munro, R, Chan, WY, O'Dowd, V, Doyle, C, Mori, P, Popplewell, A, Rossjohn, J, Lightwood, D, Ogg, GS

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms by Ramberger, M, Berretta, A, Tan, JMM, Sun, B, Michael, S, Yeo, T, Theorell, J, Bashford-Rogers, R, Paneva, S, O'Dowd, V, Dedi, N, Topia, S, Griffin, R, Ramirez-Franco, J, El Far, O, Baulac, S, Leite, MI, Sen, A, Jeans, A, McMillan, D, Marshall, D, Anthony, D, Lightwood, D, Waters, P, Irani, SR

Therapeutic monoclonal antibodies for Ebola virus infection derived from vaccinated humans by Rijal, P, Elias, SC, Machado, SR, Xiao, J, Schimanski, L, O'Dowd, V, Baker, T, Barry, E, Mendelsohn, SC, Cherry, CJ, Jin, J, Labbé, GM, Donnellan, FR, Rampling, T, Dowall, S, Rayner, E, Findlay-Wilson, S, Carroll, M, Guo, J, Xu, X-N, Huang, K-YA, Takada, A, Burgess, G, McMillan, D, Popplewell, A, Lightwood, DJ, Draper, SJ, Townsend, AR